Biosafety Management: Emphasis on Medicine, Pharmacy, and Biotechnology
DOI:
https://doi.org/10.20535/ibb.2025.9.2.329014References
Orelle A, Nikiema A, Zakaryan A, Albetkova AA, Rayfield MA, Peruski LF, et al. National Biosafety Management System: A Combined Framework Approach Based on 15 Key Elements. Frontiers in Public Health. 2021;9:609107. DOI: 10.3389/fpubh.2021.609107
Albert C, Baez A, Rutland J. Human security as biosecurity Reconceptualizing national security threats in the time of COVID-19. Politics and the Life Sciences. 2021;40(1):83-105. DOI: 10.1017/pls.2021.1
Pawar SD, Kode SS, Keng SS, Tare DS, Abraham P. Steps, implementation and importance of quality management in diagnostic laboratories with special emphasis on coronavirus disease-2019. Indian Journal of Medical Microbiology. 2020;38(3-4):243-51. DOI: 10.4103/ijmm.IJMM_20_353
Joseph T. Management System Approach for Addressing Biosafety and Biosecurity of Emerging Pathogens in a Biosafety Level-3 Core Facility. Applied Biosafety. 2021;26(4):210-20. DOI: 10.1089/apb.2021.0007
Krynina OI, Romaniuk SI, Gorbatiuk OB, Korchynskyi OH, Rebriiev АV, Kulyk YaS, et al. Production of recombinant SARS-COV-2 proteins and diphtheria toxoid CRM197-based fusion. The Ukrainian Biochemical Journal. 2021;93(6):31-45. DOI: 10.15407/ubj93.06.031
Galkin A, Arkhypova M, Starosyla D, Deriabin O, Vasylchenko O, Rybalko S, Golembiovska O. Antiviral activity of new flavonoids-containing phytopreparation against human alphaherpesvirus 2, hepatitis C virus, and coronavirus. Research Square; 2022. DOI: 10.21203/rs.3.rs-1773246/v1
Kashuba VI, Hryshchenko NV, Gerashchenko GV, Melnichuk NS, Marchishak TV, Chernushyn SYu, et al. Identification and characterization of the SARS-CoV-2 lineage B.1.1.7 upon the new outbreak of the COVID-19 in Ukraine in February 2021. Biopolymers and Cell. 2021;37(2):117-24. DOI: 10.7124/bc.000A52
Nesteruk I. Epidemic waves caused by SARS-CoV-2 omicron (B.1.1.529) and pessimistic forecasts of the COVID-19 pandemic duration. MedComm. 2022;3(1):e122. DOI: 10.1002/mco2.122
International projects – Biomedicine and Bioengineering Association. Bmbe.pro. Available from: https://bmbe.pro/en/international-projects/
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 The Author(s)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The ownership of copyright remains with the Authors.
Authors may use their own material in other publications provided that the Journal is acknowledged as the original place of publication and National Technical University of Ukraine “Igor Sikorsky Kyiv Polytechnic Institute” as the Publisher.
Authors are reminded that it is their responsibility to comply with copyright laws. It is essential to ensure that no part of the text or illustrations have appeared or are due to appear in other publications, without prior permission from the copyright holder.
IBB articles are published under Creative Commons licence:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under CC BY 4.0 that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
